Found 263 matching trials
Neoadjuvant-Adjuvant Pembrolizumab in Resectable Advanced Basal Cell Carcinoma of H&N PHASE1 The purpose of this study is to evaluate anti-PD-1 Neoadjuvant therapy in B...
Show More Location
Cleveland Clinic, Case Comprehensive Cancer Center
Learn More & Join Trial
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer PHASE2 This is a single-arm open-label multi-cohort Phase II study evaluating the ...
Show More Status
Active Not Recruiting
Location
NYU Perlmutter Cancer Center
Learn More & Join Trial
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer PHASE1 The reason for this study is to see if the CD73 inhibitor LY3475070 alone o...
Show More Location
Sarah Cannon Research Institute at HealthOne
Learn More & Join Trial
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002) PHASE3 The purpose of this study is to evaluate the efficacy and safety of pembrol...
Show More Location
Department of minimally invasive esophageal surgery, Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma N/A This study is conducted to evaluate the efficacy, prognosis, adverse effect...
Show More Location
The Second Affiliated Hospital of Fujian Medical University
Learn More & Join Trial
A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors PHASE1 Phase 1/2a Clinical Trial of BI-1206, a Monoclonal Antibody to CD32b (FcγRI...
Show More Location
University of California Los Angeles
Learn More & Join Trial
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma PHASE1 The purpose of this study is to find out whether IMPRINT in combination wit...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited protocol activities)
Learn More & Join Trial
Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression PHASE2 Clinical Indication : HER mutated or HER2 Amplification/Overexpression in G...
Show More Location
Yonsei University Health System, Severance Hospital
Learn More & Join Trial
Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: PHASE1 This is an open label, multi-institutional, single arm study of dose escala...
Show More Location
Northwestern University, Robert H. Lurie Cancer Center
Learn More & Join Trial
Study of Healthy Donor FMT (hdFMT) and Pembrolizumab in Relapsed/Refractory (R/R) PD-L1 Positive NSCLC PHASE2 This study is to determine if Healthy Donor FMT (hdFMT) improves the body's...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial